-
With the Supreme Court about to hear a landmark case on gene patents, Myriad Genetics, the company that owns the patents under scrutiny, is going on the offensive.
FORBES: Myriad Genetics CEO Claims He Owns Your Genes
-
His initial idea was to use gene databases being churned out by genetics maverick J.
FORBES: Health Care
-
Back in 2003, Kathryn North and colleagues at the University of Sydney published a paper in a leading genetics journal about a gene called ACTN3.
FORBES: Genetic tests for kids' sports abilities: hype or science?
-
Initially she inserted the gene using bacteria, but then her colleagues managed to breed the ancient rice with modern varieties using genetics-assisted breeding technologies, which transferred the flood-resistance gene and not much else.
FORBES: Green Genes
-
Now Myriad Genetics is pushing a proprietary 46-gene test that predicts whether your prostate cancer will kill you.
FORBES: Gene Tests That Predict When You Will Die
-
For example, DeCode last week published a paper describing a gene related to stroke in the scientific journal Nature Genetics.
FORBES: Magazine Article
-
Last month Myriad Genetics said it had discovered an obesity gene.
FORBES: Hunger Pangs
-
Numerous companies including 23andme, Decode Genetics, and Navigenics, now sell gene tests or gene scans that purport to identify your risk of various common diseases.
FORBES: Why You Shouldn't Trust Newfangled Gene Tests
-
DeCode Genetics announced this morning that it had found a gene linked to obesity, prompting a milestone payment from its partner Merck .
FORBES: Magazine Article
-
In one of the largest-ever studies of genetics and autism, researchers have identified 24 new gene variants associated with autism spectrum disorders (ASD).
FORBES: Autism And Genetics: It's Complicated
-
Patient groups are sponsoring drug discovery at other firms, including Iceland's Decode Genetics and England's Oxford BioMedica, which is plying a gene-therapy approach.
FORBES: Companies, People, Ideas
-
In contrast, a genomics firm like Iceland's DeCode Genetics (nasdaq: DCGN - news - people ) might apply for 350 gene patents--as DeCode did today--that might make money someday, but still post a loss.
FORBES: Genencor, P&G Deal Highlights Enzyme Market